CA2356099A1 - Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux - Google Patents

Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux Download PDF

Info

Publication number
CA2356099A1
CA2356099A1 CA002356099A CA2356099A CA2356099A1 CA 2356099 A1 CA2356099 A1 CA 2356099A1 CA 002356099 A CA002356099 A CA 002356099A CA 2356099 A CA2356099 A CA 2356099A CA 2356099 A1 CA2356099 A1 CA 2356099A1
Authority
CA
Canada
Prior art keywords
increased
cartilage
mammal
articular cartilage
degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002356099A
Other languages
English (en)
Inventor
Jean-Pierre Pelletier
Johanne Martel-Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascentia Pharma Inc
Merckle GmbH
Original Assignee
Ascentia Pharma Inc
Merckle GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascentia Pharma Inc, Merckle GmbH filed Critical Ascentia Pharma Inc
Priority to CA002356099A priority Critical patent/CA2356099A1/fr
Priority to CA002457540A priority patent/CA2457540A1/fr
Priority to HU0401283A priority patent/HUP0401283A2/hu
Priority to MXPA04001868A priority patent/MXPA04001868A/es
Priority to BR0212244-8A priority patent/BR0212244A/pt
Priority to EP02797552A priority patent/EP1427410A1/fr
Priority to RU2004109227/15A priority patent/RU2303447C2/ru
Priority to JP2003524574A priority patent/JP2005504781A/ja
Priority to NZ531226A priority patent/NZ531226A/en
Priority to PCT/EP2002/009658 priority patent/WO2003020267A1/fr
Priority to CNA028170806A priority patent/CN1549711A/zh
Priority to UA2004032301A priority patent/UA81229C2/uk
Priority to US10/486,912 priority patent/US7425573B2/en
Publication of CA2356099A1 publication Critical patent/CA2356099A1/fr
Priority to IS7166A priority patent/IS7166A/is
Priority to ZA200402440A priority patent/ZA200402440B/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002356099A 2001-08-30 2001-08-30 Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux Abandoned CA2356099A1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CA002356099A CA2356099A1 (fr) 2001-08-30 2001-08-30 Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux
JP2003524574A JP2005504781A (ja) 2001-08-30 2002-08-29 環付加したピロール化合物の関節軟骨または軟骨下骨変性の治療における使用
NZ531226A NZ531226A (en) 2001-08-30 2002-08-29 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
MXPA04001868A MXPA04001868A (es) 2001-08-30 2002-08-29 Uso de compuestos de pirrol anillados en el tratamiento de la degeneracion del hueso sub-condrial o cartilago articular.
BR0212244-8A BR0212244A (pt) 2001-08-30 2002-08-29 Uso de um ou mais do que um composto e seus isÈmeros ópticos, derivados e sais fisiologicamente aceitáveis, composição farmacêutica, e, método de tratamento ou de prevenção da degeneração ou da destruição de cartilagem articular e/ou de osso subcondral em uma ou mais articulações de um mamìfero
EP02797552A EP1427410A1 (fr) 2001-08-30 2002-08-29 Utilisation de composes de pyrrole anneles dans le traitement de la degenerescence d'un cartilage articulaire ou d'un os sous-chondral
RU2004109227/15A RU2303447C2 (ru) 2001-08-30 2002-08-29 Применение аннелированных соединений пиррола при лечении дегенерации суставного хряща или структурных изменений субхондральной кости
CA002457540A CA2457540A1 (fr) 2001-08-30 2002-08-29 Utilisation de composes de pyrrole anneles dans le traitement de la degenerescence d'un cartilage articulaire ou d'un os sous-chondral
HU0401283A HUP0401283A2 (hu) 2001-08-30 2002-08-29 Annellált pirrolvegyületek alkalmazása ízületi porc vagy porc melletti csont elfajulásának kezelésére, és ezeket tartalmazó gyógyszerkészítmények
PCT/EP2002/009658 WO2003020267A1 (fr) 2001-08-30 2002-08-29 Utilisation de composes de pyrrole anneles dans le traitement de la degenerescence d'un cartilage articulaire ou d'un os sous-chondral
CNA028170806A CN1549711A (zh) 2001-08-30 2002-08-29 稠合的吡咯化合物在治疗关节软骨或软骨下骨组织退化中的用途
UA2004032301A UA81229C2 (en) 2001-08-30 2002-08-29 Use of [6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl]-acetic acid in the treatment of articular cartilage or subchondral bone degeneration
US10/486,912 US7425573B2 (en) 2001-08-30 2002-08-29 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
IS7166A IS7166A (is) 2001-08-30 2004-02-27 Notkun annellataðra pýrrólsambanda í meðhöndlun áliðabrjósks- eða neðanbrjósksbeinahrörnun
ZA200402440A ZA200402440B (en) 2001-08-30 2004-03-29 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002356099A CA2356099A1 (fr) 2001-08-30 2001-08-30 Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux

Publications (1)

Publication Number Publication Date
CA2356099A1 true CA2356099A1 (fr) 2003-02-28

Family

ID=4169830

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002356099A Abandoned CA2356099A1 (fr) 2001-08-30 2001-08-30 Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux

Country Status (3)

Country Link
CA (1) CA2356099A1 (fr)
UA (1) UA81229C2 (fr)
ZA (1) ZA200402440B (fr)

Also Published As

Publication number Publication date
ZA200402440B (en) 2004-10-07
UA81229C2 (en) 2007-12-25

Similar Documents

Publication Publication Date Title
EP0970694B1 (fr) Utilisation du carprofène et ses dérivés pour la prévention ou le traitement de la dégénération articulaire
JP6982747B2 (ja) 変形性関節症の処置
US7425573B2 (en) Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
Hayami et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model
RU2723559C2 (ru) Комбинированная терапия с применением препарата ценикривирок для лечения фиброза
RU2435585C2 (ru) Антагонисты рецептора эндотелина, предназначенные для ранней стадии идиопатического фиброза легких
WO2017048322A1 (fr) Polythérapie faisant appel au cénicriviroc pour le traitement de la fibrose
WO2008109057A1 (fr) Composés organiques et leurs utilisations
JP2006516571A (ja) 良性前立腺増殖症の処置
Jin et al. A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration
JP2007063288A (ja) エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法
Oldroyd et al. Endothelin: what does the radiologist need to know?
Evans et al. Nitric oxide in arthritis
JP2014517037A (ja) Ｂｃａｔ１阻害剤を使用する治療方法
AU2002333757B2 (en) Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
CA2356099A1 (fr) Utilisation de composes de pyrolle annele dans le traitement du cartilage articulaire ou de la degenerescence des os sous- chondraux
CA2457540A1 (fr) Utilisation de composes de pyrrole anneles dans le traitement de la degenerescence d'un cartilage articulaire ou d'un os sous-chondral
AU2002333757A1 (en) Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
JP2005519098A (ja) 変形性関節症の治療方法
KR20030007314A (ko) 카르프로펜 및 그의 유도체를 포함하는, 포유류에서 관절연골 또는 연골하 골의 초기 단계의 퇴행을 치료 또는예방하기 위한 약학적 조성물 및 팩키지

Legal Events

Date Code Title Description
FZDE Dead